Awakn Life Sciences Corp. (AWKNF)
USD 0.07
(0.0%)
USD 0.07
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | 87.37 Thousand | 1.49 Million | 236.03 Thousand | - |
| Cost of Revenue | 18.29 Thousand | 603.53 Thousand | 512.87 Thousand | - |
| Gross Profit | 69.07 Thousand | 891.8 Thousand | -276.83 Thousand | - |
| Operating Expenses | 87.37 Thousand | 10.08 Million | 9.84 Million | 1.46 Million |
| Selling, General and Administrative Expenses | 3.16 Million | 8.51 Million | 6.53 Million | 823.06 Thousand |
| Research and Development Expenses | 827.81 Thousand | 1.57 Million | 3.3 Million | - |
| Other Expenses | - | -2374.00 | 10.35 Thousand | - |
| Cost and Expenses | 3.99 Million | 10.68 Million | 10.03 Million | 1.46 Million |
| Operating Income | -3.9 Million | -9.19 Million | -9.79 Million | -840.3 Thousand |
| Interest Expense | - | 266.51 Thousand | 205.42 Thousand | - |
| Income Tax Expense | - | -509.01 Thousand | -525.87 Thousand | -215.29 Thousand |
| Earnings before Tax | -3.67 Million | -9.65 Million | -16.47 Million | -1.47 Million |
| Net Income | -5.1 Million | -9.14 Million | -15.94 Million | -1.25 Million |
| Earnings Per Share Basic | -0.13 | -0.36 | -0.73 | -0.10 |
| Earnings Per Share Diluted | -0.18 | -0.36 | -0.73 | -0.10 |
| Weighted Average Shares Outstanding | 39.68 Million | 25.2 Million | 21.96 Million | 12.62 Million |
| Weighted Average Shares Outstanding (Diluted) | 29.06 Million | 25.2 Million | 21.96 Million | 12.62 Million |
| Gross Margin | 0.79 | 0.60 | -1.17 | - |
| EBIT Margin | -44.73 | -5.74 | -40.72 | - |
| Profit Margin | -58.40 | -6.11 | -67.56 | - |
| EBITDA | -3.9 Million | -5.26 Million | -16.08 Million | -840.21 Thousand |
| Earnings Before Tax Margin | -44.73 | -6.15 | -41.49 | - |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Revenue | 87.37 Thousand | 21.81 Thousand | 28.94 Thousand | 24.62 Thousand | 510.76 Thousand | 1.49 Million |
| Cost of Revenue | 18.29 Thousand | 4768.00 | 6306.00 | 3611.00 | 171.19 Thousand | 603.53 Thousand |
| Gross Profit | 69.07 Thousand | 17.05 Thousand | 22.63 Thousand | 21.01 Thousand | 339.57 Thousand | 891.8 Thousand |
| Operating Expenses | 3.99 Million | 859.45 Thousand | 697.56 Thousand | 1.48 Million | 2.29 Million | 10.08 Million |
| Selling, General and Administrative Expenses | - | 607.51 Thousand | 508.58 Thousand | 1.24 Million | 2.07 Million | - |
| Research and Development Expenses | - | 251.94 Thousand | 188.97 Thousand | 238.92 Thousand | 219.1 Thousand | - |
| Other Expenses | - | - | - | - | -545.00 | -2374.00 |
| Cost and Expenses | 4.01 Million | 864.21 Thousand | 703.86 Thousand | 1.48 Million | 2.46 Million | 10.68 Million |
| Operating Income | -3.92 Million | -842.4 Thousand | -674.93 Thousand | -1.46 Million | -1.95 Million | -9.19 Million |
| Interest Expense | - | - | - | - | 68.21 Thousand | 266.51 Thousand |
| Income Tax Expense | 1.34 Million | -290.31 Thousand | 4.00 | 598.8 Thousand | -91.17 Thousand | -509.01 Thousand |
| Earnings before Tax | -3.67 Million | -1.31 Million | -647.23 Thousand | -1.15 Million | -1.68 Million | -9.65 Million |
| Net Income | -5.01 Million | -1.02 Million | -647.23 Thousand | -1.75 Million | -1.58 Million | -9.14 Million |
| Earnings Per Share Basic | - | -0.03 | -0.02 | -0.06 | -0.06 | - |
| Earnings Per Share Diluted | - | -0.03 | -0.02 | -0.06 | -0.06 | - |
| Weighted Average Shares Outstanding | 29.06 Million | 39.09 Million | 30.51 Million | 28.74 Million | 25.34 Million | 25.2 Million |
| Weighted Average Shares Outstanding (Diluted) | 29.06 Million | 39.09 Million | 30.51 Million | 28.74 Million | 25.34 Million | 25.2 Million |
| Gross Margin | 0.79 | 0.78 | 0.78 | 0.85 | 0.66 | 0.60 |
| EBIT Margin | - | -38.39 | -23.10 | -59.27 | -3.48 | - |
| Profit Margin | -57.36 | -46.98 | -22.36 | -71.08 | -3.11 | -6.11 |
| EBITDA | - | -837.63 Thousand | -668.62 Thousand | -1.45 Million | -1.77 Million | - |
| Earnings Before Tax Margin | -44.94 | -38.61 | -23.32 | -59.42 | -3.82 | -6.15 |
BLOIN
TCC
TIMESGTY
BOMTALKIES
002937
000975